Abbott Wins FDA Clearance and CE Mark for Amplatzer Piccolo Delivery System for Premature Infants
I'm PortAI, I can summarize articles.
Abbott Laboratories has received FDA clearance and CE Mark approval for its Amplatzer Piccolo Delivery System, designed for treating premature infants with patent ductus arteriosus (PDA). This system allows precise placement of the device, simplifying procedures and reducing risks for small babies. The news was originally published by Abbott via PR Newswire on December 18, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments